nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—PHKG2—brainstem—narcolepsy	0.0525	0.0867	CbGeAlD
Afatinib—ERBB4—brainstem—narcolepsy	0.0472	0.0779	CbGeAlD
Afatinib—ERBB4—forebrain—narcolepsy	0.0456	0.0752	CbGeAlD
Afatinib—DYRK1A—brainstem—narcolepsy	0.0455	0.075	CbGeAlD
Afatinib—DYRK1A—forebrain—narcolepsy	0.0439	0.0724	CbGeAlD
Afatinib—PHKG2—medulla oblongata—narcolepsy	0.0366	0.0604	CbGeAlD
Afatinib—ERBB4—medulla oblongata—narcolepsy	0.0329	0.0544	CbGeAlD
Afatinib—ERBB4—midbrain—narcolepsy	0.0301	0.0497	CbGeAlD
Afatinib—HIPK4—brain—narcolepsy	0.0276	0.0455	CbGeAlD
Afatinib—ERBB2—Leptin signaling pathway—SOCS2—narcolepsy	0.024	0.0608	CbGpPWpGaD
Afatinib—IRAK1—midbrain—narcolepsy	0.0225	0.0372	CbGeAlD
Afatinib—EPHA6—brain—narcolepsy	0.0218	0.036	CbGeAlD
Afatinib—PHKG2—brain—narcolepsy	0.021	0.0347	CbGeAlD
Afatinib—ABL1—brainstem—narcolepsy	0.0198	0.0327	CbGeAlD
Afatinib—ERBB4—brain—narcolepsy	0.0189	0.0312	CbGeAlD
Afatinib—ERBB2—brain—narcolepsy	0.0189	0.0312	CbGeAlD
Afatinib—DYRK1A—brain—narcolepsy	0.0182	0.03	CbGeAlD
Afatinib—DYRK1A—Circadian rythm related genes—HCRTR1—narcolepsy	0.0172	0.0438	CbGpPWpGaD
Afatinib—DYRK1A—Circadian rythm related genes—HCRTR2—narcolepsy	0.0172	0.0438	CbGpPWpGaD
Afatinib—EGFR—brain—narcolepsy	0.016	0.0265	CbGeAlD
Afatinib—LCK—IL2-mediated signaling events—SOCS2—narcolepsy	0.0145	0.0369	CbGpPWpGaD
Afatinib—ERBB4—EV release from cardiac cells and their functional effects—TNF—narcolepsy	0.0145	0.0367	CbGpPWpGaD
Afatinib—IRAK1—brain—narcolepsy	0.0141	0.0233	CbGeAlD
Afatinib—ABL1—medulla oblongata—narcolepsy	0.0138	0.0228	CbGeAlD
Afatinib—ABL1—midbrain—narcolepsy	0.0126	0.0208	CbGeAlD
Afatinib—LCK—Translocation of ZAP-70 to Immunological synapse—HLA-DQA1—narcolepsy	0.00955	0.0242	CbGpPWpGaD
Afatinib—LCK—Inflammatory Response Pathway—TNFRSF1B—narcolepsy	0.00926	0.0235	CbGpPWpGaD
Afatinib—LCK—Translocation of ZAP-70 to Immunological synapse—HLA-DQB1—narcolepsy	0.00894	0.0227	CbGpPWpGaD
Afatinib—LCK—Phosphorylation of CD3 and TCR zeta chains—HLA-DQA1—narcolepsy	0.00878	0.0223	CbGpPWpGaD
Afatinib—ABCG2—medulla oblongata—narcolepsy	0.0087	0.0144	CbGeAlD
Afatinib—LCK—Phosphorylation of CD3 and TCR zeta chains—HLA-DQB1—narcolepsy	0.00821	0.0208	CbGpPWpGaD
Afatinib—ABCG2—midbrain—narcolepsy	0.00795	0.0131	CbGeAlD
Afatinib—ABL1—brain—narcolepsy	0.00792	0.0131	CbGeAlD
Afatinib—LCK—PD-1 signaling—HLA-DQA1—narcolepsy	0.00785	0.0199	CbGpPWpGaD
Afatinib—DYRK1A—Circadian rythm related genes—NPS—narcolepsy	0.0078	0.0198	CbGpPWpGaD
Afatinib—BLK—Apoptosis Modulation and Signaling—TNFRSF1B—narcolepsy	0.00775	0.0197	CbGpPWpGaD
Afatinib—LCK—PD-1 signaling—HLA-DQB1—narcolepsy	0.00734	0.0186	CbGpPWpGaD
Afatinib—LCK—Translocation of ZAP-70 to Immunological synapse—HLA-DRB1—narcolepsy	0.00679	0.0172	CbGpPWpGaD
Afatinib—LCK—Phosphorylation of CD3 and TCR zeta chains—HLA-DRB1—narcolepsy	0.00625	0.0158	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—SOCS2—narcolepsy	0.00604	0.0153	CbGpPWpGaD
Afatinib—LCK—Generation of second messenger molecules—HLA-DQA1—narcolepsy	0.00603	0.0153	CbGpPWpGaD
Afatinib—ABCB1—forebrain—narcolepsy	0.00594	0.0098	CbGeAlD
Afatinib—IRAK1—Apoptosis Modulation and Signaling—TNFRSF1B—narcolepsy	0.00591	0.015	CbGpPWpGaD
Afatinib—LCK—Generation of second messenger molecules—HLA-DQB1—narcolepsy	0.00564	0.0143	CbGpPWpGaD
Afatinib—LCK—PD-1 signaling—HLA-DRB1—narcolepsy	0.00558	0.0142	CbGpPWpGaD
Afatinib—ABCG2—brain—narcolepsy	0.005	0.00825	CbGeAlD
Afatinib—LCK—Downstream TCR signaling—HLA-DQA1—narcolepsy	0.00494	0.0125	CbGpPWpGaD
Afatinib—LCK—Downstream TCR signaling—HLA-DQB1—narcolepsy	0.00463	0.0117	CbGpPWpGaD
Afatinib—ABCB1—medulla oblongata—narcolepsy	0.00429	0.00708	CbGeAlD
Afatinib—LCK—Generation of second messenger molecules—HLA-DRB1—narcolepsy	0.00429	0.0109	CbGpPWpGaD
Afatinib—IRAK1—EBV LMP1 signaling—TNF—narcolepsy	0.0041	0.0104	CbGpPWpGaD
Afatinib—BLK—CXCR4-mediated signaling events—HLA-DRB1—narcolepsy	0.00403	0.0102	CbGpPWpGaD
Afatinib—ABCB1—midbrain—narcolepsy	0.00392	0.00647	CbGeAlD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00392	0.00994	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00392	0.00994	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—SOCS2—narcolepsy	0.00389	0.00988	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CHKB—narcolepsy	0.00379	0.00963	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00378	0.0096	CbGpPWpGaD
Afatinib—LCK—TCR signaling—HLA-DQA1—narcolepsy	0.0037	0.00938	CbGpPWpGaD
Afatinib—LCK—Downstream TCR signaling—HLA-DRB1—narcolepsy	0.00352	0.00892	CbGpPWpGaD
Afatinib—LCK—TCR signaling—HLA-DQB1—narcolepsy	0.00346	0.00877	CbGpPWpGaD
Afatinib—LCK—Costimulation by the CD28 family—HLA-DQA1—narcolepsy	0.0033	0.00837	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00322	0.00816	CbGpPWpGaD
Afatinib—LCK—Costimulation by the CD28 family—HLA-DQB1—narcolepsy	0.00309	0.00783	CbGpPWpGaD
Afatinib—ERBB2—Immune System—SOCS2—narcolepsy	0.00273	0.00693	CbGpPWpGaD
Afatinib—ERBB4—Immune System—SOCS2—narcolepsy	0.00269	0.00682	CbGpPWpGaD
Afatinib—LCK—TCR signaling—HLA-DRB1—narcolepsy	0.00263	0.00667	CbGpPWpGaD
Afatinib—LCK—IL12-mediated signaling events—HLA-DRB1—narcolepsy	0.00259	0.00658	CbGpPWpGaD
Afatinib—BLK—Immune System—SOCS2—narcolepsy	0.00259	0.00656	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CPT1B—narcolepsy	0.00258	0.00655	CbGpPWpGaD
Afatinib—ABCB1—brain—narcolepsy	0.00246	0.00407	CbGeAlD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00244	0.00619	CbGpPWpGaD
Afatinib—LCK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—narcolepsy	0.0024	0.0061	CbGpPWpGaD
Afatinib—LCK—Costimulation by the CD28 family—HLA-DRB1—narcolepsy	0.00235	0.00595	CbGpPWpGaD
Afatinib—LCK—CXCR4-mediated signaling events—HLA-DRB1—narcolepsy	0.00198	0.00503	CbGpPWpGaD
Afatinib—IRAK1—Immune System—SOCS2—narcolepsy	0.00197	0.00501	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00177	0.00449	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00177	0.00449	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.00165	0.00419	CbGpPWpGaD
Afatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—narcolepsy	0.00164	0.00417	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00157	0.00399	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00157	0.00399	CbGpPWpGaD
Afatinib—ABL1—Immune System—SOCS2—narcolepsy	0.00154	0.00392	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.00154	0.00392	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00153	0.00389	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00143	0.00364	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HCRTR1—narcolepsy	0.00139	0.00351	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HCRTR2—narcolepsy	0.00139	0.00351	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HCRTR2—narcolepsy	0.00136	0.00346	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HCRTR1—narcolepsy	0.00136	0.00346	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—P2RY11—narcolepsy	0.00134	0.00339	CbGpPWpGaD
Afatinib—EGFR—Immune System—SOCS2—narcolepsy	0.00132	0.00335	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—P2RY11—narcolepsy	0.00132	0.00334	CbGpPWpGaD
Afatinib—LCK—Immune System—SOCS2—narcolepsy	0.00127	0.00323	CbGpPWpGaD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.00124	0.00316	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00123	0.00312	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00121	0.00307	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.00117	0.00298	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00116	0.00295	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—HLA-DQB1—narcolepsy	0.00115	0.00292	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HCRT—narcolepsy	0.00114	0.00289	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HCRTR1—narcolepsy	0.00113	0.00288	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HCRTR2—narcolepsy	0.00113	0.00288	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—HLA-DQB1—narcolepsy	0.00113	0.00287	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HCRT—narcolepsy	0.00112	0.00284	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—P2RY11—narcolepsy	0.00109	0.00278	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00109	0.00277	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—HLA-DQB1—narcolepsy	0.00109	0.00276	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00107	0.0027	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.00106	0.0027	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00104	0.00264	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PENK—narcolepsy	0.00101	0.00257	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HCRTR2—narcolepsy	0.001	0.00254	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HCRTR1—narcolepsy	0.001	0.00254	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PENK—narcolepsy	0.000999	0.00253	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000995	0.00252	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000971	0.00246	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—P2RY11—narcolepsy	0.000967	0.00245	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HCRT—narcolepsy	0.000931	0.00236	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000874	0.00222	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TRH—narcolepsy	0.000862	0.00219	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000861	0.00218	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CHKB—narcolepsy	0.000849	0.00215	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TRH—narcolepsy	0.000849	0.00215	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—PENK—narcolepsy	0.00083	0.00211	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000828	0.0021	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HCRT—narcolepsy	0.000822	0.00209	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000756	0.00192	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HRH3—narcolepsy	0.000756	0.00192	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HLA-DQA1—narcolepsy	0.000745	0.00189	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HRH3—narcolepsy	0.000745	0.00189	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TNF—narcolepsy	0.00074	0.00188	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HLA-DQA1—narcolepsy	0.000734	0.00186	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PENK—narcolepsy	0.000733	0.00186	CbGpPWpGaD
Afatinib—BLK—Immune System—HLA-DQA1—narcolepsy	0.000706	0.00179	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TRH—narcolepsy	0.000705	0.00179	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HLA-DQB1—narcolepsy	0.000697	0.00177	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HLA-DQB1—narcolepsy	0.000687	0.00174	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HCRTR2—narcolepsy	0.00067	0.0017	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HCRTR1—narcolepsy	0.00067	0.0017	CbGpPWpGaD
Afatinib—BLK—Immune System—HLA-DQB1—narcolepsy	0.000661	0.00168	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—TNF—narcolepsy	0.000658	0.00167	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—P2RY11—narcolepsy	0.000647	0.00164	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HCRTR2—narcolepsy	0.000645	0.00164	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HCRTR1—narcolepsy	0.000645	0.00164	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NPS—narcolepsy	0.000626	0.00159	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TAC1—narcolepsy	0.000626	0.00159	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TRH—narcolepsy	0.000623	0.00158	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—P2RY11—narcolepsy	0.000623	0.00158	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HRH3—narcolepsy	0.000619	0.00157	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TAC1—narcolepsy	0.000617	0.00157	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NPS—narcolepsy	0.000617	0.00157	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000594	0.00151	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000589	0.0015	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CPT1B—narcolepsy	0.000577	0.00146	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000573	0.00145	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TNF—narcolepsy	0.000558	0.00142	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000556	0.00141	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HCRT—narcolepsy	0.00055	0.0014	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HRH3—narcolepsy	0.000546	0.00139	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-DQA1—narcolepsy	0.000539	0.00137	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000536	0.00136	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HLA-DRB1—narcolepsy	0.00053	0.00135	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HCRT—narcolepsy	0.00053	0.00134	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HLA-DRB1—narcolepsy	0.000522	0.00133	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000515	0.00131	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—NPS—narcolepsy	0.000513	0.0013	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TAC1—narcolepsy	0.000513	0.0013	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-DQB1—narcolepsy	0.000504	0.00128	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000504	0.00128	CbGpPWpGaD
Afatinib—BLK—Immune System—HLA-DRB1—narcolepsy	0.000502	0.00127	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PENK—narcolepsy	0.00049	0.00124	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—TNF—narcolepsy	0.000487	0.00124	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PENK—narcolepsy	0.000472	0.0012	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CHKB—narcolepsy	0.000459	0.00116	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TAC1—narcolepsy	0.000453	0.00115	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NPS—narcolepsy	0.000453	0.00115	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000423	0.00107	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-DQA1—narcolepsy	0.000422	0.00107	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TRH—narcolepsy	0.000417	0.00106	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000407	0.00103	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TRH—narcolepsy	0.000402	0.00102	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-DQB1—narcolepsy	0.000394	0.001	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-DRB1—narcolepsy	0.000383	0.000973	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2A—narcolepsy	0.000377	0.000956	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2A—narcolepsy	0.000371	0.000942	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HRH3—narcolepsy	0.000365	0.000927	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DQA1—narcolepsy	0.00036	0.000914	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HRH3—narcolepsy	0.000352	0.000894	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DQA1—narcolepsy	0.000347	0.000881	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DQB1—narcolepsy	0.000337	0.000855	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DQB1—narcolepsy	0.000325	0.000824	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CPT1B—narcolepsy	0.000312	0.000792	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2A—narcolepsy	0.000308	0.000782	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TAC1—narcolepsy	0.000303	0.000768	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NPS—narcolepsy	0.000303	0.000768	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-DRB1—narcolepsy	0.0003	0.000761	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NPS—narcolepsy	0.000292	0.00074	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TAC1—narcolepsy	0.000292	0.00074	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—narcolepsy	0.000276	0.000699	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2A—narcolepsy	0.000272	0.000691	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DRB1—narcolepsy	0.000256	0.00065	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000254	0.000645	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DRB1—narcolepsy	0.000247	0.000627	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—narcolepsy	0.000236	0.000598	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—narcolepsy	0.000182	0.000462	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—narcolepsy	0.000176	0.000445	CbGpPWpGaD
